Domov › Melanóm › Utah › Salt Lake City
Klinické štúdie Melanóm v meste Salt Lake City, UT
21 štúdií pre Melanóm hľadá účastníkov v zariadeniach v meste Salt Lake City a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
Prebieha náborFáza 2
- Huntsman Cancer Institute, Salt Lake City
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Prebieha náborFáza 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Prebieha náborFáza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Prebieha náborFáza 3
- Intermountain Health, Salt Lake City
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Prebieha náborFáza 2
- Primary Children's Hospital, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Prebieha náborFáza 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Prebieha náborFáza 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Prebieha náborObservačná štúdia
- Utah Cancer Specialists, Salt Lake City
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
Prebieha náborFáza 1/2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Project: Every Child for Younger Patients With Cancer
Prebieha náborObservačná štúdia
- Primary Children's Hospital, Salt Lake City
Rural Adult and Youth Sun Protection Study
Prebieha náborVítaní zdravých dobrovoľníkov
- University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Prebieha náborFáza 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Prebieha nábor
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Prebieha nábor
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Prebieha náborFáza 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Prebieha náborFáza 3
- Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
Prebieha náborFáza 1/2
- Huntsman Cancer Institute, Salt Lake City
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Prebieha náborFáza 1/2
- Huntsman Cancer Institute - University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Prebieha nábor
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Štúdie Melanóm v iných mestách
- Houston, TX59 štúdií
- New York City, NY38 štúdií
- Los Angeles, CA34 štúdií
- Nashville, TN33 štúdií
- Pittsburgh, PA31 štúdií
- Boston, MA26 štúdií
- Philadelphia, PA23 štúdií
- San Francisco, CA22 štúdií
- Columbus, OH21 štúdií
- Durham, NC21 štúdií
- Atlanta, GA21 štúdií
- St. Louis, MO21 štúdií
Iné štúdie v Salt Lake City
- Nemalobunkový karcinóm pľúc31 štúdií
- Rakovina (všetky typy)27 štúdií
- Rakovina prsníka27 štúdií
- Kolorektálny karcinóm22 štúdií
- Rakovina pľúc21 štúdií
- Mnohonásobný myelóm21 štúdií
- Metastatická rakovina20 štúdií
- Rakovina vaječníkov19 štúdií
- Obézita18 štúdií
- Akútna myeloidná leukémia17 štúdií
- Srdcové zlyhanie17 štúdií
- Rakovina prostaty15 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.